These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 23404680)
1. Functional UDP-glucuronyltransferase 2B15 polymorphism and bisphenol A concentrations in blood: results from physiologically based kinetic modelling. Partosch F; Mielke H; Gundert-Remy U Arch Toxicol; 2013 Jul; 87(7):1257-64. PubMed ID: 23404680 [TBL] [Abstract][Full Text] [Related]
2. 24-hour human urine and serum profiles of bisphenol A: Evidence against sublingual absorption following ingestion in soup. Teeguarden JG; Twaddle NC; Churchwell MI; Yang X; Fisher JW; Seryak LM; Doerge DR Toxicol Appl Pharmacol; 2015 Oct; 288(2):131-42. PubMed ID: 25620055 [TBL] [Abstract][Full Text] [Related]
3. Effect of UDP-glucuronosyltransferase 2B15 polymorphism on bisphenol A glucuronidation. Hanioka N; Oka H; Nagaoka K; Ikushiro S; Narimatsu S Arch Toxicol; 2011 Nov; 85(11):1373-81. PubMed ID: 21404072 [TBL] [Abstract][Full Text] [Related]
4. Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation. Hanioka N; Naito T; Narimatsu S Chemosphere; 2008 Dec; 74(1):33-6. PubMed ID: 18990428 [TBL] [Abstract][Full Text] [Related]
5. In vitro evidence for endocrine-disrupting chemical (EDC)'s inhibition of drug metabolism. Li WP; Wang YF; Gao J; Yu ML; Yu YY; Yao YQ Afr Health Sci; 2014 Mar; 14(1):185-8. PubMed ID: 26060477 [TBL] [Abstract][Full Text] [Related]
6. Butyl paraben and propyl paraben modulate bisphenol A and estradiol concentrations in female and male mice. Pollock T; Weaver RE; Ghasemi R; deCatanzaro D Toxicol Appl Pharmacol; 2017 Jun; 325():18-24. PubMed ID: 28390971 [TBL] [Abstract][Full Text] [Related]
7. Bisphenol A in chronic kidney disease. Krieter DH; Canaud B; Lemke HD; Rodriguez A; Morgenroth A; von Appen K; Dragoun GP; Wanner C Artif Organs; 2013 Mar; 37(3):283-90. PubMed ID: 23145999 [TBL] [Abstract][Full Text] [Related]
8. New insights for the risk of bisphenol A: inhibition of UDP-glucuronosyltransferases (UGTs). Jiang HM; Fang ZZ; Cao YF; Hu CM; Sun XY; Hong M; Yang L; Ge GB; Liu Y; Zhang YY; Dong Q; Liu RJ Chemosphere; 2013 Oct; 93(6):1189-93. PubMed ID: 23948605 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of bisphenol A in humans following a single oral administration. Thayer KA; Doerge DR; Hunt D; Schurman SH; Twaddle NC; Churchwell MI; Garantziotis S; Kissling GE; Easterling MR; Bucher JR; Birnbaum LS Environ Int; 2015 Oct; 83():107-15. PubMed ID: 26115537 [TBL] [Abstract][Full Text] [Related]
10. Development of a physiologically based pharmacokinetic model for assessment of human exposure to bisphenol A. Yang X; Doerge DR; Teeguarden JG; Fisher JW Toxicol Appl Pharmacol; 2015 Dec; 289(3):442-56. PubMed ID: 26522835 [TBL] [Abstract][Full Text] [Related]
11. Physiologically Based Pharmacokinetic (PBPK) Modeling of the Bisphenols BPA, BPS, BPF, and BPAF with New Experimental Metabolic Parameters: Comparing the Pharmacokinetic Behavior of BPA with Its Substitutes. Karrer C; Roiss T; von Goetz N; Gramec Skledar D; Peterlin Mašič L; Hungerbühler K Environ Health Perspect; 2018 Jul; 126(7):077002. PubMed ID: 29995627 [TBL] [Abstract][Full Text] [Related]
12. Elevated serum bisphenol A levels under hyperandrogenic conditions may be caused by decreased UDP-glucuronosyltransferase activity. Takeuchi T; Tsutsumi O; Ikezuki Y; Kamei Y; Osuga Y; Fujiwara T; Takai Y; Momoeda M; Yano T; Taketani Y Endocr J; 2006 Aug; 53(4):485-91. PubMed ID: 16829708 [TBL] [Abstract][Full Text] [Related]
13. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide. Kurebayashi H; Betsui H; Ohno Y Toxicol Sci; 2003 May; 73(1):17-25. PubMed ID: 12700409 [TBL] [Abstract][Full Text] [Related]
14. Toxicokinetics of bisphenol A in rats, monkeys and chimpanzees by the LC-MS/MS method. Tominaga T; Negishi T; Hirooka H; Miyachi A; Inoue A; Hayasaka I; Yoshikawa Y Toxicology; 2006 Sep; 226(2-3):208-17. PubMed ID: 16914249 [TBL] [Abstract][Full Text] [Related]
15. Extrapolation of plasma clearance to understand species differences in toxicokinetics of bisphenol A. Poet T; Hays S Xenobiotica; 2018 Sep; 48(9):891-897. PubMed ID: 29027834 [TBL] [Abstract][Full Text] [Related]
16. Allometric scaling for predicting human clearance of bisphenol A. Collet SH; Picard-Hagen N; Lacroix MZ; Puel S; Viguié C; Bousquet-Melou A; Toutain PL; Gayrard V Toxicol Appl Pharmacol; 2015 May; 284(3):323-9. PubMed ID: 25759244 [TBL] [Abstract][Full Text] [Related]
17. The effect of genetic polymorphisms in UGT2B15 on the pharmacokinetic profile of sipoglitazar, a novel anti-diabetic agent. Stringer F; Scott G; Valbuena M; Kinley J; Nishihara M; Urquhart R Eur J Clin Pharmacol; 2013 Mar; 69(3):423-30. PubMed ID: 22960998 [TBL] [Abstract][Full Text] [Related]
18. Prediction and evaluation of route dependent dosimetry of BPA in rats at different life stages using a physiologically based pharmacokinetic model. Yang X; Doerge DR; Fisher JW Toxicol Appl Pharmacol; 2013 Jul; 270(1):45-59. PubMed ID: 23566954 [TBL] [Abstract][Full Text] [Related]
19. Gender difference in serum bisphenol A levels may be caused by liver UDP-glucuronosyltransferase activity in rats. Takeuchi T; Tsutsumi O; Nakamura N; Ikezuki Y; Takai Y; Yano T; Taketani Y Biochem Biophys Res Commun; 2004 Dec; 325(2):549-54. PubMed ID: 15530427 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of bisphenol A in neonatal and adult rhesus monkeys. Doerge DR; Twaddle NC; Woodling KA; Fisher JW Toxicol Appl Pharmacol; 2010 Oct; 248(1):1-11. PubMed ID: 20655935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]